Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders
Rhee TG, Rosenheck RA. Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders. Journal Of Affective Disorders 2019, 252: 450-457. PMID: 31004825, PMCID: PMC6520147, DOI: 10.1016/j.jad.2019.04.018.Peer-Reviewed Original ResearchConceptsPsychotropic polypharmacyDepressive disorderDepressed adultsPsychiatric careNational Ambulatory Medical Care SurveyPsychiatric multimorbidityAmbulatory Medical Care SurveyPrevalence of polypharmacyAdjunctive treatment strategyMore psychotropic medicationsOutpatient psychiatric careContext of multimorbidityPrescription combinationsPsychiatric polypharmacyPsychotropic classesPsychotropic medicationsCare SurveyPolypharmacyTreatment strategiesMultimorbidityAdultsCareAntipsychoticsAntidepressantsDisorders
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply